1-9 of 9
Koichiro Minauchi
Close
Sort by
Journal Articles

Genetic Mutation and Outcome of Venetoclax-Based Therapy in Newly Diagnosed AML in the Real World: Hokkaido Leukemia Net Study

Naoki Miyashita, Masahiro Onozawa, Jun Nagai, Shota Yoshida, Hiroyuki Kimura, Toshihiro Matsukawa, Shinsuke Hirabayashi, Akio Mori, Takeshi Kondo, Daisuke Hidaka, Koichiro Minauchi, Akio Shigematsu, Junichi Hashiguchi, Tetsuyuki Igarashi, Yasutaka Kakinoki, Yutaka Tsutsumi, Hiroshi Iwasaki, Shota Yokoyama, Kentaro Wakasa, Katsuya Fujimoto, Toshimichi Ishihara, Hajime Sakai, Satoshi Iyama, Tatsuo Oyake, Takanori Teshima
Journal: Blood
Blood (2023) 142 (Supplement 1): 1470.
https://doi.org/10.1182/blood-2023-173909
Published: 2023
Journal Articles

Clinical Features of Complex Karyotype in Newly Diagnosed Acute Myeloid Leukemia

Shota Yoshida, Masahiro Onozawa, Naoki Miyashita, Hiroyuki Kimura, Shogo Takahashi, Shota Yokoyama, Toshihiro Matsukawa, Shinsuke Hirabayashi, Akio Mori, Takeshi Kondo, Daisuke Hidaka, Koichiro Minauchi, Akio Shigematsu, Junichi Hashiguchi, Tetsuyuki Igarashi, Yasutaka Kakinoki, Yutaka Tsutsumi, Hiroshi Iwasaki, Hajime Kobayashi, Yoshihito Haseyama, Katsuya Fujimoto, Toshimichi Ishihara, Hajime Sakai, Satoshi Iyama, Takanori Teshima
Journal: Blood
Blood (2022) 140 (Supplement 1): 3210–3211.
https://doi.org/10.1182/blood-2022-157874
Published: 2022
Journal Articles

High Metabolic Heterogeneity on Baseline 18F-FDG PET/CT Predicts Worse Prognosis of Newly Diagnosed Diffuse Large B-Cell Lymphoma

Hajime Senjo, MD, Kenji Hirata, MD PhD, Koh Izumiyama, MD PhD, Koichiro Minauchi, MD, Kazuo Itoh, Eriko Tsukamoto, Akio Mori, Shuichi Ota, Daigo Hashimoto, Takanori Teshima, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 488.
https://doi.org/10.1182/blood-2019-124390
Published: 2019
Journal Articles

Serum Soluble Interleukin-2 Receptor As a Surrogate Biomarker of Metabolic Tumor Volume Measured By 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma

Hajime Senjo, MD, Minoru Kanaya, MDPhD, Koh Izumiyama, MDPhD, Koichiro Minauchi, MD, Kenji Hirata, MDPhD, Akio Mori, Makoto Saito, Masanori Tanaka, Hiroaki Iijima, Eriko Tsukamoto, Kazuo Itoh, Shuichi Ota, MD, Masanobu Morioka, Daigo Hashimoto, MD, PhD, Takanori Teshima
Journal: Blood
Blood (2018) 132 (Supplement 1): 345.
https://doi.org/10.1182/blood-2018-99-111076
Published: 2018
Journal Articles

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

Yoshitoyo Kagami, MD, Kazuhito Yamamoto, MDPhD, Taro Shibata, MSc, Kensei Tobinai, MD PhD, Yoshitaka Imaizumi, MD PhD, Toshiki Uchida, MD PhD, Kazuyuki Shimada, MD, Koichiro Minauchi, MD, Noriko Fukuhara, MD PhD, Hirofumi Kobayashi, MD PhD, Nobuhiko Yamauchi, MD, Hideki Tsujimura, MD PhD, Akira Hangaishi, MD, Ryo Tominaga, MD, Youko Suehiro, MD, Shinichiro Yoshida, MD PhD, Yoshiko Inoue, MD, Sachiko Suzuki, MD, Michihide Tokuhira, MD, Hirokazu Nagai, MD PhD, Shigeru Kusumoto, MD, Junya Kuroda, MD PhD, Yoshihiro Yakushijin, MD PhD, Yasushi Takamatsu, MD PhD, Yasushi Kubota, MD PhD, Kisato Nosaka, MD, Satoko Morishima, MD PhD, Shigeo Nakamura, MD PhD, Dai Maruyama, MD PhD, Tomomitsu Hotta, MD, Yasuo Morishima, MD PhD, Kunihiro Tsukasaki, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4127.
https://doi.org/10.1182/blood.V130.Suppl_1.4127.4127
Published: 2017
Journal Articles

Targeting Complete Response with Upfront Bortezomib Followed By Autologous Transplantation and Consolidation Therapy for Untreated Multiple Myeloma (TUBA study)

Hideki Nakasone, MD/PhD, Kiriko Terasako-Saito, Teiichi Hirano, MD, Atsushi Wake, MD PhD, Seiichi Shimizu, MD PhD, Etsuko Yamazaki, MD PhD, Kouhei Akazawa, Kensuke Usuki, MD PhD, Shigeru Chiba, MD, PhD, Koichiro Minauchi, MD, Etsuo Miyaoka, Shuichi Ota, MD, Shuichi Taniguchi, MD PhD, Yoshinobu Kanda, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3463.
https://doi.org/10.1182/blood.V128.22.3463.3463
Published: 2016
Journal Articles

Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience

Koichiro Minauchi, MD, Masato Obara, MD, PhD, Takahide Ara, MD, Kanako Shima, MD, Atsushi Yasumoto, MD, PhD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Yoshio Kiyama, MD, Masahiro Ogasawara, MD, PhD, Naoki Kobayashi, MD, PhD, Masahiro Imamura, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2697.
https://doi.org/10.1182/blood.V122.21.2697.2697
Published: 2013
Journal Articles

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Masahiro Ogasawara, MD, Ph.D, Tomohiro Yamakawa, MD, Yuki Katsura, MD, Kanako Shima, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Koichiro Minauchi, MD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Naoki Kobayashi, MD, Ph.D, Yoshio Kiyama, MD, Naoto Hirano, MD, Ph.D
Journal: Blood
Blood (2010) 116 (21): 2101.
https://doi.org/10.1182/blood.V116.21.2101.2101
Published: 2010
Journal Articles

Absence of an IgD−/CD27+ Switched Memory B Cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant Therapy after Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma.

Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, Satoshi Yamamoto, MD, PhD, Toshiya Sakai, MD, Masato Obara, MD, Koki Kumano, MD, Koichiro Minauchi, MD, Masayuki Yamakura, MD, Norihiro Sato, MD, PhD, Takao Koike, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1412.
https://doi.org/10.1182/blood.V106.11.1412.1412
Published: 2005